Taltz 80 mg Injection

Taltz 80 mg Injection contains Ixekizumab  is a high-affinity monoclonal antibody designed for patients who require systemic therapy for autoimmune inflammatory conditions. By specifically targeting Interleukin-17A (IL-17A), Taltz stops the inflammatory cycle that leads to thick, scaly skin plaques and painful joint swelling. It is one of the fastest-acting biologics available for achieving clear skin.

Key Benefits of Taltz Therapy

• Superior Skin Clearance: Most patients achieve PASI 90 (90% clear skin) within the first 12 weeks of treatment.

• Joint Protection: Prevents the progression of joint damage in Psoriatic Arthritis and Ankylosing Spondylitis.

• Rapid Itch Relief: Significantly reduces psoriasis-related itching and skin pain shortly after the first dose.

• Convenient Delivery: Available in an easy-to-use autoinjector with a hidden needle for a stress-free experience.

Taltz is administered via subcutaneous injection. A "loading dose" is typically required to ensure the medication reaches therapeutic levels quickly:

• Plaque Psoriasis: 160 mg (two 80 mg injections) at Week 0, followed by 80 mg every 2 weeks through Week 12, then 80 mg every 4 weeks.

• Psoriatic Arthritis / AS: 160 mg (two 80 mg injections) at Week 0, followed by 80 mg every 4 weeks.

• Injection Sites: Administer in the thigh, abdomen, or back of the upper arm. Rotate sites with each dose.

Storage and Cold Chain Requirements

As a protein-based biologic, Taltz must be handled with strict temperature control:

• Refrigeration: Must be stored in a refrigerator at 2°C to 8°C.

• Room Temperature: Can be kept out of the fridge for a single period of up to 5 days (below 30°C) for travel.

• Milan Medicals Quality: We use specialized thermal packaging and monitors to ensure your Taltz remains refrigerated during shipping to the UAE, Saudi Arabia, UK, and USA.